Monograph Details
|
|
Respiratory Tract
> Cough and cold
|
|
ALLERX DF |
| Manufacturer |
|
Cornerstone BioPharma, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antihistamine + anticholinergic. |
| Generic Name |
|
Chlorpheniramine maleate 4mg + methscopolamine nitrate 2.5mg; per AM tab; chlorpheniramine maleate 8mg + methscopolamine nitrate 2.5mg; per PM tab; scored. |
| Indications |
|
Rhinitis. |
| Children |
|
Not recommended. |
| Adults |
|
1 AM tab in the morning and 1 PM tab in the evening. |
| Contraindications |
|
Severe hypertension or coronary artery disease. Narrow-angle glaucoma. Peptic ulcer. Nursing mothers. |
| Precautions |
|
Diabetes. Cardiovascular disease. Hypertension. Autonomic neuropathy. Hepatic or renal impairment. Ulcerative colitis. Young children. Elderly. Pregnancy (Cat.C). |
| Interactions |
|
Increased anticholinergic effects with antipsychotics and tricyclic antidepressants. Antacids may interfere with methscopolamine absorption. Concomitant sildenafil: not recommended. |
| Adverse Reactions |
|
Drowsiness, anticholinergic effects, GI upset, dizziness, irritiability. |
| How Supplied |
Dose pack (20 tabs)—1 (10 AM tabs + 10 PM tabs)
Dose pack (60 tabs)—1 (30 AM tabs + 30 PM tabs) |
|
|
|
|
